DMC and Conagen enter into an agreement for commercial manufacturing of L-alanine


Type of post: NEWS IN BRIEF.

DMC Biotechnologies and Conagen have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine.
Related posts:

Figure 1. L-alanine

This partnership combines Conagen’s production expertise with DMC’s bioprocess technology and follows demonstration of commercial-scale production in March 2021. L-alanine is a naturally occurring amino acid used widely in homecare products, human nutrition, and pharmaceutical applications. DMC’s fermentation technology enables L-alanine to be produced with attractive economics as part of a regional supply chain with increased reliability and greater sustainability. DMC has a robust product pipeline, including additional amino acids, that will subsequently be brought to the market.

Popular Posts

Mini-plant for production of glucaric acid from glucose starts up successfully

Biorefinery models - Lignocellulosic biorefinery

Hidrotratamiento (HVO) – Conceptos, materias primas y especificaciones

Biobased acrylic acid

Biofuels from algae